FindTrial
Sign In

Use of dexmedetomidine intranasally as a premedication to reduce opioid uses in paediatric surgery

Intranasal Dexmedetomidine as a Premedication in Paediatric Patients to Reduce Peri-Operative Opioid Use-Prospective Randomized Control Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112998
Enrollment
60
Registered
2026-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: intranasal dexmedetomidine: premedication 2mcg/kg given intranasally via atomizer total 1 ml, 0.5 ml in each nostril , 30 mins prior to shifting patient to OT in preoperative area with

Sponsors

JSS Medical College And hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I AND II POSTED FOE AN ELECTIVE SURGERY OF LESS THAN 2 HOURS

Exclusion criteria

Exclusion criteria: PARENTS REFUSAL, PRESENCE OF CHRONIC ILLNESS, ASA III AND IV, ALLERGY TO DEXMEDETOMIDINE

Design outcomes

Primary

MeasureTime frame
IN dexmedetomidine as a premedication in paediatric anesthesia can lead to significant reduction in opioid uses both intraoperative and postoperative periods. By reducing opioid consumption, it should also reduce the opioid related side effects including, respiratory depression, postoperative nausea and vomiting and delayed recovery. Thereby improving overall perioperative experience, also enhancing recovery outcomes. Timepoint: in a peripoerative period (intraoperative period+ postoperative period of 6hours)—

Secondary

MeasureTime frame
Sedative, anxiolytic & analgesic properties of dexmedetomidine facilitate smoother induction of anesthesia & reduced parental separation anxiety . Timepoint: from 30 mins prior to surgery till induction of anaesthesia—

Countries

India

Contacts

Public ContactShrutee Amitkumar Meshram

JSS AHER

shruteemeshram@jssuni.edu.in9881710589

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026